Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

DDW: Late-Night Eating + Stress Negatively Impact Gut

The combination of stress and nighttime eating increases the likelihood of abnormal bowel habits, according to a study presented at Digestive Disease Week 2026,

Predictive Model Shows Moderate Performance for Psoriasis Relapse Risk

A predictive model for psoriasis relapse risk demonstrates moderate performance, according to a study published online April 11 in Scientific Reports. Xiaoxue Z

Study Looks at Outcomes of Endoscopic Surgery in Men With BPH, Overactive Bladder

Patients with benign prostatic hyperplasia (BPH) with preoperative overactive bladder (OAB) have higher postoperative storage symptoms despite comparable overal

DDW: 1999 to 2023 Saw Rise in Rectal Cancer Deaths in Younger Adults

Rectal cancer is occurring earlier and killing younger adults faster, according to a study presented at Digestive Disease Week 2026, held from May 2 to 5 in Chi

Diabetes Risk After Vitamin D Supplement Varies by Apal Polymorphism in Prediabetes

For adults with prediabetes, a reduction in the risk for diabetes is seen after supplementation with 4,000 IU day of vitamin D3 among those carrying the AC and

CDER Proposes to Withdraw Approval of Tavneos

Today, the Center for Drug Evaluation and Research (CDER) proposed that Tavneos (avacopan) be withdrawn from the market because new information indicates that T

Clinical Trial Finds No Difference in Fluid Treatment Options for Pediatric Sepsis

A large clinical trial supported by the National Institutes of Health (NIH) compared two commonly used treatments for pediatric patients treated for septic shoc

Symptom-Based Approach Treats Opioid Withdrawal in Newborns with Minimal Drug Exposure

A National Institutes of Health (NIH)-funded clinical study shows that a symptom-based treatment for babies with neonatal opioid withdrawal syndrome (NOWS) a hi

GSK’s Investigational Liver Therapy, Efimosfermin, Receives US FDA Breakthrough Therapy and EMA Priority Medicines (PRIME) Designations for MASH

GSK plc (LSE NYSE GSK) today announced that efimosfermin, a once-monthly investigational liver therapy, has been granted Breakthrough Therapy Designation by the

Estrogen Patch Shortages Likely Driven By Empowered Women Seeking Relief, Expert Says

MONDAY, April 27, 2026 A new generation of empowered women could be driving the estrogen patch shortages now bedeviling the United States, the medical director

Popular Keywords